Trials / Conditions / Refractory Myelodysplastic Syndromes
Refractory Myelodysplastic Syndromes
3 registered clinical trials studyying Refractory Myelodysplastic Syndromes.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS NCT06846606 | Auron Therapeutics, Inc. | Phase 1 |
| Active Not Recruiting | FHD-286 as Monotherapy or Combination Therapy in Subjects With Advanced Hematologic Malignancies NCT04891757 | Foghorn Therapeutics Inc. | Phase 1 |
| Active Not Recruiting | NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS NCT04623944 | Nkarta, Inc. | Phase 1 |